Business Daily from THE HINDU group of publications
Friday, Aug 22, 2008
ePaper | Mobile/PDA Version | Audio
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Standards & Benchmarks
Aurobindo's Losartan gets US nod

Hyderabad, Aug. 21

Aurobindo Pharma Ltd has received the tentative approval to manufacture and market Losartan Potassium tablets from the US Food & Drug Administration (USFDA). The drug is used in the treatment of hypertension. Losartan Potassium tablets are the generic equivalent of Merck Research Laboratories' Cozaar tablets and falls in the antihypertensive segment. The branded sales of Losartan range of products was $1,235 million for the year ended December 2007, the company said. - Our Bureau

More Stories on : Standards & Benchmarks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Some relief for Tata Motors investors

Gas supply row: Possibility of Ambani brothers meeting emerges
MRPL pays dividend to HPCL
Hindustan Zinc proposes Rs 3,600-cr expansion
Nagarjuna Const. bags new orders
Lupin picks up minority stake in Australian company
Environ Energy plans polysilicon project
SABMiller sees profit decline in Indian operations
Pride Hotels expanding overseas
Tulsyan NEC signs pact with Nigerian co
Harita Seating plans venture with German co
Wipro Infra, Cargotec in pact
PBEL unveils Hyderabad project
When waste paper collection is good business plan
Tata Motors fails to sustain initial gains
Aurobindo's Losartan gets US nod
Volkswagen to launch two mini vans by year-end
Sports car Audi R8 gets 15 bookings so far
Delhi will get Suzuki’s brand display centre
Empee Sugars plans corporate farming of cane
Zee forays into trade show biz, targets Rs 10 cr turnover
Leyland heavy haulage vehicle sales up
R.S. Pandey set to join Petronet board




Brandline
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line